No. Your Cord Blood Bank Does Not Have to Grow Slowly.
As I hung up the phone, one sentence hung in my mind:
“I realized in my first read-through that there are more than a dozen triggers that could grow my cord blood bank – not tomorrow, now.”
This statement was part of a phone conversation I had with a client this week who took the time to thank me for his decision to invest in the “Complete 2015-16 Global Cord Blood Banking Industry Report.” He admitted that when he researched the product, he broadly searched for business intelligence about the cord blood marketplace.
However, after settling on the “Complete 2015-16 Global Cord Blood Banking Industry Report” as the only product in the marketplace that contains business intelligence data – i.e. data that analyzes competitive business opportunities and conditions – he found that this product had several qualities that differentiated it within the marketplace and made it essential to the management decisions that he has to make within his cord blood bank.
He initially came across the report after reading this popular article on our site, “Geographical Differences in Cord Blood Banking: 6 Regions with Unusual Market Activity.” This post explores six regions that have experienced unusual cord blood market activity or change, usually because of a shift in government policy surrounding cord blood banking. It is vital to understand cord blood market risks, as well as market opportunities, across different regions of the world, because trends in one area can impact neighboring regions. On a larger scale, these risks and opportunities can create global shifts within the industry.
This particular client was from a country in Asia that was experiencing very rapid change, so he understood first-hand just how quickly the cord blood banking industry can evolve.
The points below summarize key elements of the “Complete 2015-16 Global Cord Blood Banking Industry Report” and why this client found his investment in this product so valuable.
What Makes the Complete 2015-16 Cord Blood Banking Industry Report” Unique?
First, metrics within this global strategic report are based on ten-years of historical data, because BioInformant has been tracking the industry from 2006 to present. Indeed, BioInformant is the first and only market research firm specializing in the cord blood industry.
Importantly, we also use continuously maintained dashboards of key cord blood industry metrics, combined with a system of alerts that get triggered when industry metrics exhibit unexpected variation. This allows us to identify key industry trends, long before the competition.
The report also contains a 40-question, 52-page survey of 600+ recent and expectant parents worldwide, that explores how to strategically position cord blood and tissue services, effectively educate parents, prioritize a marketing budget, and more. No other market report for the cord blood industry contains these direct insights from recent and expectant parents – the people who buy your services.
The report also comes with free access to BioInformant’s “Global Cord Blood Banking Industry Database 2015-16” (value of $1,195). This database contains every active cord blood bank worldwide (nearly 500), plus 3,500+ contacts for individuals operating within the global cord blood industry. Sort it by country, company name, or contact details, to assess competition within any region of interest. (You can also claim this database separately.)
Finally, the report includes “12-Months of free 1-on-1 Consulting” (value of $1,495). With this service, you get direct access to our team of cord blood industry experts for a full year. Ask us questions about how to incorporate the report findings into your company or discuss new strategic plans. No other company has the capacity to offer you this level of expertise and support. We are so confident that you will become one of our happy clients that the report is also accompanied by our Greater than 100% Money Back Guarantee.
Remember, to profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the marketplace, and take advantage of crucial trends.
Claim this report now to profit from this expanding market – or your competition will: https://www.bioinformant.com/product/complete-2015-16-global-cord-blood-banking-industry-report/
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant research has been cited on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data. Click here to view our global strategic reports for the stem cell and cord blood industry.
Want to be better informed than your competition? Get future stem cell and cord blood industry updates.